Controlling ribosomal RNA could help researchers target diseases driven by too little or too much protein production.
Researchers used AI to create variants of a CRISPR-Cas12-like nuclease, some of which show increased editing activity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results